Search Results
is certainly the domain of a philosopher, who can guide discussions to better help a patient connect with an existing, or newfound, system of values. The use of MDMA in couples' therapy provides a glimpse of how values can change. Such therapy may
, N. , Eckert , A. , … Liechti , M. ( 2020 ). Distinct acute effects of LSD, MDMA, and D-amphetamine in healthy subjects . Neuropsychopharmacology , 45 ( 3 ), 462 – 471 . Johnson , M. W. , Garcia-Romeu , A. , Cosimano , M. P
recently defined by the journal Psychedelic Medicine as serotonergic agonists that expand brain network connectivity by activating 5-HT2A receptors. They include classic psychedelics (psilocybin, mescaline, DMT, and LSD) as well as ketamine and MDMA
, alcohol, tobacco, and cannabis) were linked to higher scores of dimensions linked to mental health impairment, and lower scores of dimensions linked to well-being and resilience. Within this last group of non-psychedelic drugs, MDMA showed different
hallucinogens: eight participants. – Psilocybin: (“magic mushrooms”) ranging from one trial to monthly use, and from 1-year use up to 10 years; – LSD: ranging from one trial to monthly use, and from 1-year use up to 10 years; – MDMA (Ecstasy): ranging from one
mystical experiences and fewer challenging experiences after actual use. In a more recent report of MDMA users, Elmer, Vannoy, Studerus, and Lyubomirsky (2024) found significant differences by types of intentions for the majority of positive social
, A. , Jerome , L. , Mithoefer , A. , Wagner , M. , Walsh , Z. , Hamilton , S. , Yazar-Klosinski , B. , Emerson , A. & Doblin , R. ( 2019 ). MDMA-Assisted psychotherapy for treatment of PTSD: Study design and rationale for phase 3
is a member of a closed ayahuasca Facebook group, approximately between 22 and 67 years old and holds a rather high education degree and might be preexperienced in psychedelics such as psilocybin (“magic mushrooms”), MDMA (“ecstasy”), cannabis, and
) reported on the efficacy of MDMA and psilocybin in treating symptoms of PTSD and depression, but noted that confounders, patient bias, and challenges associated with blinding remain. Recent articles provide a valuable analysis of methodological problems
“relive the drug taking experience in their imagination” ( Baumann, 1970 , p. 20) with similar findings indicated more recently in a group of 3,4-Methylenedioxymethamphetamine (MDMA) users ( Hastings, 2006 ) suggesting the re-accessing of psychedelic
